PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.
Continuous glucose monitoring yields modest reductions in hemoglobin A1c levels in adults with type 2 diabetes compared with standard care.
Elevated maternal body mass index and excessive weight gain during pregnancy increase the risk of early-onset CVD in offspring.
Glucagon-like peptide-1 receptor agonists improve obstructive sleep apnea outcomes in obesity, primarily through significant ...
Tirzepatide therapy reduces the risk for major adverse cardiovascular events in patients with type 2 diabetes and established CVD.
The FDA has approved Degevma (denosumab-adet), a new biosimilar to Xgeva, to prevent skeletal-related events in patients with bone metastases.
Emerging evidence suggests that hematologic biomarkers may aid in early recognition and triage of endometriosis. This is a syndicated post stub. Endocrinology Advisor, a trusted source of medical news ...
Endocrinology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results